Search research articles
Contact Us
Filters
Showing results (101-110 of 169) with videos related to
Page
of 17
Sort By:
European Journal of Medicinal Chemistry
|
August 11, 2019
Small molecule modulators targeting protein kinase CK1 and CK2
Yuting Qiao, Tingkai Chen, Hongyu Yang, et al.
European Journal of Medicinal Chemistry
|
February 27, 2025
Discovery of highly potent AKR1Cs pan-inhibitors as chemotherapeutic potentiators to restore breast cancer drug resistance
Shuaishuai Xing, Yijun Liu, Huanfang Xie, et al.
Journal of Medicinal Chemistry
|
January 30, 2026
Discovery of Highly Selective AKR1C3 Inhibitors to Overcome EGFR C797S-Mediated Osimertinib Resistance in Non-Small Cell Lung Cancer
Can Guo, Xiaolong Wang, Qianwen Guan, et al.
Cancer Science
|
May 2, 2026
AKR1C3 Binds β-Trcp to Promote the Degradation of TFRC to Protect Hepatocellular Carcinoma From Ferroptosis
Lei Qi, Jingyi Hua, Di Pan, et al.
Bioorganic Chemistry
|
October 14, 2023
Recent advances in targeting leucine-rich repeat kinase 2 as a potential strategy for the treatment of Parkinson's disease
Ruiwei Cao, Caiping Chen, Jing Wen, et al.
International Journal of Biological Macromolecules
|
November 8, 2020
Synthesis and bio-evaluation of a novel selective butyrylcholinesterase inhibitor discovered through structure-based virtual screening
Shuaishuai Xing, Ying Chen, Baichen Xiong, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
April 14, 2018
Small molecule KDM4s inhibitors as anti-cancer agents
Hongzhi Lin, Qihang Li, Qi Li, et al.
Biochemical Pharmacology
|
June 10, 2026
FSP1, a key ferroptosis suppressor with therapeutic potential
Xiaoxue Bai, Jiawei Zhu, Baichen Xiong, et al.
Journal of Medicinal Chemistry
|
February 9, 2023
The Development and Design Strategy of Leucine-Rich Repeat Kinase 2 Inhibitors: Promising Therapeutic Agents for Parkinson's Disease
Xu Tang, Shuaishuai Xing, Mingkang Ma, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 2, 2025
HDAC6/Trim21 aggravates macrophage inflammatory response and titanium-induced osteolysis via GSDMD signaling pathway
Junxi Chen, Taihe Liu, Jiankai Luo, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 169) with videos related to
Sort By:
Page
of 17
European Journal of Medicinal Chemistry
|
August 11, 2019
Small molecule modulators targeting protein kinase CK1 and CK2
Yuting Qiao, Tingkai Chen, Hongyu Yang, et al.
European Journal of Medicinal Chemistry
|
February 27, 2025
Discovery of highly potent AKR1Cs pan-inhibitors as chemotherapeutic potentiators to restore breast cancer drug resistance
Shuaishuai Xing, Yijun Liu, Huanfang Xie, et al.
Journal of Medicinal Chemistry
|
January 30, 2026
Discovery of Highly Selective AKR1C3 Inhibitors to Overcome EGFR C797S-Mediated Osimertinib Resistance in Non-Small Cell Lung Cancer
Can Guo, Xiaolong Wang, Qianwen Guan, et al.
Cancer Science
|
May 2, 2026
AKR1C3 Binds β-Trcp to Promote the Degradation of TFRC to Protect Hepatocellular Carcinoma From Ferroptosis
Lei Qi, Jingyi Hua, Di Pan, et al.
Bioorganic Chemistry
|
October 14, 2023
Recent advances in targeting leucine-rich repeat kinase 2 as a potential strategy for the treatment of Parkinson's disease
Ruiwei Cao, Caiping Chen, Jing Wen, et al.
International Journal of Biological Macromolecules
|
November 8, 2020
Synthesis and bio-evaluation of a novel selective butyrylcholinesterase inhibitor discovered through structure-based virtual screening
Shuaishuai Xing, Ying Chen, Baichen Xiong, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
April 14, 2018
Small molecule KDM4s inhibitors as anti-cancer agents
Hongzhi Lin, Qihang Li, Qi Li, et al.
Biochemical Pharmacology
|
June 10, 2026
FSP1, a key ferroptosis suppressor with therapeutic potential
Xiaoxue Bai, Jiawei Zhu, Baichen Xiong, et al.
Journal of Medicinal Chemistry
|
February 9, 2023
The Development and Design Strategy of Leucine-Rich Repeat Kinase 2 Inhibitors: Promising Therapeutic Agents for Parkinson's Disease
Xu Tang, Shuaishuai Xing, Mingkang Ma, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 2, 2025
HDAC6/Trim21 aggravates macrophage inflammatory response and titanium-induced osteolysis via GSDMD signaling pathway
Junxi Chen, Taihe Liu, Jiankai Luo, et al.
Page
of 17